Abbott Laboratories (NYSE:ABT) Position Lifted by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 34.6% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 249,000 shares of the healthcare product maker’s stock after buying an additional 64,000 shares during the […]

Leave a Reply

Your email address will not be published.

Previous post IRS delays reporting rules for users of Venmo, Cash App and other payment apps
Next post Capasso Planning Partners LLC Increases Position in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA)